Higashiyama RI, Horinouchi H, Kuchiba A, Matsumoto Y, et al. Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients. J Cancer Res Clin Oncol 2022 Jul 28. pii: 10.1007/s00432-022-04205.
PMID: 35900471